Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 17,72117,740 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Cancer-prone cell states of the fallopian tubal epithelium
NATIONAL CANCER INSTITUTE Cornell University United States 2021 – 2026

Project Summary Ovarian/extra-uterine high-grade serous carcinoma (HGSC) is the most common and aggressive type of ovarian cancer. It often has no symptoms at early stages and over...

$4.21M
USD
Completed NON-SBIR/STTR RPGS
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT SUMMARY Metastasis is the main cause of deaths related to malignant melanoma. Studies over the last decade have revealed that the metastatic process is not primarily driven...

$4.09M
USD
Completed NON-SBIR/STTR RPGS
Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

ABSTRACT Patients with HER2 positive (HER2+) breast cancer (~14% of breast cancer patients) have a high risk of developing brain metastases (34%). The development of novel HER2 tar...

$4.58M
USD
Completed NON-SBIR/STTR RPGS
Drug eluting injectable biomaterials for next generation chemoembolization
NATIONAL CANCER INSTITUTE Mayo Clinic Arizona United States 2021 – 2026

Abstract Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a major worldwide public health concern because it is often detected at advanced stages where trea...

$6.5M
USD
Completed NON-SBIR/STTR RPGS
Immunity to commensal papillomaviruses for cancer therapy
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2026

Project Summary/Abstract: Research in the field of microbiome has largely focused on the beneficial effects of commensal bacteria in regulating tissue homeostasis and the immune re...

$5.27M
USD
Completed NON-SBIR/STTR RPGS
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

It has been widely accepted that distinct epithelial to mesenchymal transition (EMT) phenotype and cancer stem cell (CSC) properties as well as the immunosuppressive tumor microenv...

$3.45M
USD
Completed NON-SBIR/STTR RPGS
SCH: Personalized Rescheduling of Adaptive Radiation Therapy for Head & Neck Cancer
NATIONAL CANCER INSTITUTE Rice University United States 2021 – 2025

Head and neck cancers (HNCs) account for nearly 3% of all cancers in the U.S. and most commonly affect aging individuals. While chemo-radiotherapy is the standard treatment approac...

$2.47M
USD
Completed TRAINING, INDIVIDUAL
The transcriptional and epigenetic landscape of cell fate changes in murine pancreatic cancer initiation and metastasis
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2021 – 2023

Project Summary Pancreatic cancer, the fourth most lethal cancer in the United States and rising, represents 3% of all cancer cases diagnosed per year but a disproportionate 8% of...

$467.5K
USD
Completed NON-SBIR/STTR RPGS
A Registry-Based Study of Patterns of Use of Targeted Therapies for Metastatic Cancers in Diverse Populations
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2021 – 2025

One of the most important cancer care advances in recent history is the rapid dissemination of targeted therapies (molecularly targeted kinase inhibitors and immune checkpoint inhi...

$6.5M
USD
Completed NON-SBIR/STTR RPGS
Microfluidic tumor tissue processing platform for single cell diagnostics
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2021 – 2024

ABSTRACT Solid tumors are diverse ecosystems of different cell types, and this heterogeneity has been implicated as a key factor driving disease progression, metastasis, and drug r...

$3.74M
USD
Completed NON-SBIR/STTR RPGS
A high-throughput platform to identify selective allosteric inhibitors of the PLC-y isozymes
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2025

ABSTRACT The two PLC-gamma isozymes (PLC-gamma1, -gamma2) are central to the relay and amplification of signals originating from numerous receptor tyrosine kinases and immune recep...

$5.7M
USD
Completed NON-SBIR/STTR RPGS
Chromosome 1q ceRNAs in Melanoma Progression and Metastasis
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2021 – 2026

PROJECT SUMMARY Metastasis is the main cause of deaths related to malignant melanoma. Studies over the last decade have revealed that the metastatic process is not primarily driven...

$4.17M
USD
Completed NON-SBIR/STTR RPGS
Identifying the active factor of an anti-inflammatory chemopreventive bacterium
NATIONAL CANCER INSTITUTE Tufts University Boston United States 2021 – 2022

Project Abstract/Summary Colorectal cancer (CRC) remains a major public health issue, with approximately 145,000 new cases and 51,000 deaths from this disease per year in the US al...

$1.57M
USD
Completed TRAINING, INDIVIDUAL
Investigating contributions of BRCA2 DNA-binding domains toward maintaining genome integrity
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2021 – 2026

ABSTRACT Conserved mechanisms exist to eliminate DNA damage, which, if left unrepaired, can cause gene mutations and genome rearrangements to trigger neoplastic cell transformation...

$358.4K
USD
Completed NON-SBIR/STTR RPGS
Dual function of HSP70 in cytoprotection of tumor cells and generation of permissive microenvironment
NATIONAL CANCER INSTITUTE Augusta University United States 2021 – 2026

It has been widely accepted that distinct epithelial to mesenchymal transition (EMT) phenotype and cancer stem cell (CSC) properties as well as the immunosuppressive tumor microenv...

$3.52M
USD
Completed NON-SBIR/STTR RPGS
Reduction of Tumor-Positive Margins in Oncology Surgery
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2021 – 2026

Project Abstract Approximately 80% of early stage head and neck tumors undergo surgery of curative intent at some point in their treatment course. The success of this oncologic sur...

$5.63M
USD
Completed NON-SBIR/STTR RPGS
Integrative molecular dissection of acquired resistance to PD1/PD-L1 blockade in localized and metastatic urothelial carcinoma
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

Project Summary/Abstract Metastatic urothelial carcinoma (mUC) is generally incurable with modest survival benefit provided by first-line cisplatin-based chemotherapy and post-plat...

$4.76M
USD
Completed TRAINING, INDIVIDUAL
Defining the role of Taiman, the Drosophila homolog of AIB1, as a super-competitor in developing epithelia
NATIONAL CANCER INSTITUTE Emory University United States 2021 – 2024

PROJECT SUMMARY Invasive breast cancer is a deadly disease, killing ~42,000 women each year and costing the United States over $16.5 billion annually.The complicated disease mechan...

$460.4K
USD
Completed NON-SBIR/STTR RPGS
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2024

Hydroxyapatite (HAP), Ca10(PO4)6OH2, once thought to be solely an ubiquitous component of bone, has not only been shown to be directly produced by breast malignancies.We have expan...

$4.73M
USD
Completed NON-SBIR/STTR RPGS
Repurposing Leflunomide to Delay Progression of Smoldering Multiple Myeloma in African Americans
NATIONAL CANCER INSTITUTE Beckman Research Institute/City of Hope United States 2021 – 2026

PROJECT SUMMARY Smoldering multiple myeloma (SMM) is an asymptomatic precursor of active multiple myeloma (MM), and 50 percent of patients meeting criteria for high-risk disease wi...

$7.19M
USD